Glucotrack has successfully completed its first in-human clinical study for the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein.

Glucotrack has cleared the first human clinical study of its long-term continuous glucose monitoring implant, designed to ...

Glucotrack has successfully completed a first-in-human study with its continuous glucose monitor (CGM) that directly measures ...

announced the successful completion of its first in human clinical study, marking a significant milestone in continuous glucose monitoring. This study represents the first real-time, continuous blood ...

Kent, Guo and collaborator Shaoqin Gong, a University of Wisconsin-Madison researcher, hope Pericelle will be the answer. Surgeons would apply the hydrogel paste on blood vessels to deliver a drug, ...

A nanotechnology-based drug delivery system developed at UVA Health to save patients from repeated surgeries has proved to ...

A nanotechnology-based drug delivery system to save patients from repeated surgeries has proved to have unexpectedly long-lasting benefits in lab tests - a promising sign for its potential to help ...

A nanotechnology-based drug delivery system developed to save patients from repeated surgeries has proved to have unexpectedly long-lasting benefits in lab tests -- a promising sign for its potential ...

Because it doesn’t contain living human cells ... artery or vein to a dialysis machine, as well as in individuals with peripheral artery disease, when arteries in the legs or arms become ...